Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VIKAS LIFECARE LIMITED Capital/Financing Update 2021

May 17, 2021

60454_rns_2021-05-17_9b3c51bf-c42e-4d2d-a718-8431fab5ce18.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

May 17, 2021

Listing Compliance Department National Stock Exchange of India Limited. Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai 400051 Fax: 022-26598235/36

NSE Symbol: VIKASLIFE

Listing Compliance Department BSE Limited. Phirozee Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001

Scrip Code: 542655

Sub: Intimation under Regulation 30 and 42 of the SEBI (LODR) Regulations, 2015, as amended ("SEBI Listing Regulations") and outcome of the meeting of the Board of Directors of Vikas Lifecare Limited (the "Company")

Dear Sir/ Madam,

This is further to our intimation on the outcome of the meeting of the Board of Directors of the Company ("Board") dated February 6, 2021, where the issue of fully paid-up equity shares of the Company of face value of Re. 1/- each ("Equity Shares") was approved by way of a rights issue for up to an aggregate amount of up to Rs. 50 Crore (Rupees Fifty Crore) ("Rights Issue"), in accordance with the Companies Act, 2013 and the rules made thereunder, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws and our prior intimation dated May 11, 2021.

Pursuant to the above, we wish to inform that the Board of Directors at its meeting held today, May 17, 2021 have, inter alia, considered and approved the following terms of the Rights Issue:

Sl.No. Particulars Details
1. Type of securities proposed to be Fully paid-up Equity Shares of face value of
issued Re. 1/-each ("RightsEquity Shares")
2. Type of Issuance Rights Issue of fully paid-up Equity Shares
3. Totalnumberofsecurities Up to 26,53,98,198fully paid-up Equity Shares
proposed to beissued of face value of Re. 1/-each for an amount
aggregating upto 4909.87 Lakhs.
4. Issue Price Rs. 1.85/-per Rights Equity Share (including
premium of Re. 0.85/-perRights Equity Share
5. Record Date May 21,2021 for the purpose of determining the
equityshareholders entitled to receive the
rights entitlement in the RightsIssue ("Eligible
Equity Shareholders")
6. Right Issue Period Rights Issue Opening Date: May 27, 2021
Last date for On Market Renunciation of Rights
Entitlement*: June 7, 2021
Rights Issue Closing Date**: June 10, 2021
*Eligible Equity Shareholders are requested toensure thatrenunciation through off-markettransfer is completed in such amanner that the
Rights Entitlements are credited to the demataccount of the Renouncees on or prior to theIssue Closing Date.**Our Board or a duly authorized Right Issuecommittee thereof will have theright to extendthe Issue period as it may determine from timetotime, provided that this Issue will not remainopen in excess of 30days from the IssueOpening Date (inclusive of the Issue OpeningDate). Further, no withdrawal of Applicationshall be permitted byany Applicant after theIssue Closing Date.
7. Rights Entitlement Ratio 2EquityShares for every5Equity Shares heldbythe EligibleEquity Shareholders in the Companyasontherecorddatewiththerighttorenounce.
8. Outstanding Equity Shares prior tothe Rights Issue 66,34,95,495 Equity shares of Re. 1/-each.
9. OutstandingEquitySharespostRightIssue(assumingfullsubscription) 92,88,93,693 Equity shares of Re. 1/-each.
10. Terms of payment Full amount of Rs. 1.85/-per Equity Sharepayable on application

The detailed terms of the Rights Issue including the procedure for applying in the Rights Issue and fractional entitlements will be specified in the Letter of Offer which will be filed by the Company with BSE Limited ("BSE") and National Stock Exchange of India Limited ("NSE") and with Securities and Exchange Board of India ("SEBI") for record purpose only.

This intimation is issued in terms of Regulation 30 and 42 of the SEBI Listing Regulations.

The meeting was commenced at 05:30 P.M and concluded at 7:30 P.M

You are requested to take the information on record and oblige.

Thanking you,

Yours Faithfully, for Vikas Lifecare Limited (formerly Vikas Multicorp Limited)

Rashika Gupta Company Secretary